Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index; 3 of the 31 sources its claims cite were checked for support.
Abstract
Many women with Polycystic Ovary Syndrome (PCOS) report high depression rates. The relationship between PCOS and these high depression rates is unclear. Two-component lifestyle interventions have revealed short-term effects on depression scores in this group of women. In general, 3-component interventions including diet, exercise, and cognitive behavioral therapy (CBT) are more effective in the long-term to improve emotional well-being. This has not yet been studied in women with PCOS. This study examined the effect of 20 CBT lifestyle (LS) sessions combined with a healthy diet and physical therapy with or without 9 months additional feedback through Short Message Service (SMS) via mobile phone, compared to care as usual (CAU, involving advice to lose weight). In this secondary analysis, 155 women with PCOS and a BMI above 25 kg/m2 were eligible. Depression scores decreased significantly in the LS programme compared to CAU (P = 0.045). In both the LS programme without SMS (P = 0.036) and the LS programme with SMS (P = 0.011) depression scores decreased while no change was observed in CAU (P = 0.875). Self-esteem scores improved significantly in the LS programme compared to CAU (P = 0.027). No differences in body image scores were observed in LS participants compared to CAU (P = 0.087), although body image improved significantly in both the LS without SMS (P = 0.001) and with SMS (P = 0.008) study arms. We found no significant mediating role by androgens in the relationship between LS participants and emotional well-being. Only weight-loss mediated the relationship between LS and self-esteem. To conclude, a three-component lifestyle intervention programme with or without additional SMS resulted in significant improvements in depression and self-esteem compared to CAU, in women with PCOS, obesity, and a wish to achieve a pregnancy. Testosterone, androstenedione, DHEA, insulin, HOMA-IR, and cortisol did not mediate this effect. Weight loss mediated the effects on self-esteem but not on depression and body-image. This suggests that lifestyle treatment independent of weight loss can reduce depression and body-image, but both lifestyle treatment and weight loss can improve self-esteem. Thus, a three-component lifestyle intervention based on CBT could prove successful in improving mood in women with PCOS who are overweight or obese and attempting to become pregnant.
Overview
CoChat Summary
TL;DR
In this secondary analysis of an RCT, a 1-year three-component CBT-based lifestyle intervention improved depression and self-esteem compared with care as usual in women with PCOS, overweight/obesity, and a wish to conceive. Adding SMS feedback did not clearly improve outcomes beyond the lifestyle programme alone, and androgen/insulin/cortisol measures did not mediate the well-being changes.
Key findings
- Depression decreased significantly in the lifestyle programme versus care as usual (BDI-II difference −3.44; Cohen’s d −0.41; p = 0.045). Within-group decreases were −3.7 points without SMS (d = −0.35; p = 0.036) and −3.8 points with SMS (d = −0.37; p = 0.011), while care as usual showed no change (−0.2 points; d = −0.02; p = 0.875).
- Self-esteem improved significantly in the lifestyle programme versus care as usual (RSES difference 2.65; Cohen’s d 0.46; p = 0.003 in Table 2; text reports p = 0.027). Within-group improvements were +2.6 points without SMS (p < 0.001) and +2.2 points with SMS (p = 0.002).
- Body image did not differ significantly between lifestyle and care as usual overall (FNAES difference −2.60; Cohen’s d −0.29; p = 0.094 in Table 2; text reports p = 0.087), though it improved within lifestyle without SMS (p = 0.001) and with SMS (p = 0.008).
- Mediation analyses tested 21 paths; only 4 paths were significant with self-esteem (weight loss, androstenedione, testosterone, DHEA). No paths with depression were significant, and insulin, HOMA-IR, and cortisol showed no mediation. Weight loss had a nearly significant effect on treatment-related self-esteem change (p = 0.08) but no effect on depression or body-image.
Methods
- Secondary analysis of a randomized controlled trial in women with PCOS (Rotterdam 2003 criteria), BMI >25 kg/m², aged 18–38, and attempting to become pregnant. Participants were randomized 1:1:1 to a 1-year CBT lifestyle intervention (20 group sessions of 2.5 hours), the same lifestyle intervention plus 9 months of SMS feedback, or care as usual involving advice to lose weight.
- Outcomes were measured at baseline and 3, 6, 9, and 12 months using the Beck Depression Inventory-II (BDI-II), Rosenberg Self Esteem Scale (RSES), and Fear of Negative Appearance Evaluation Scale (FNAES). Blood measures included testosterone, androstenedione, DHEA, insulin, HOMA-IR, and cortisol.
- Longitudinal multilevel regression models were used for depression, self-esteem, and body image, with Cohen’s d effect sizes and multilevel mediation analyses. Baseline analysis samples were 140 for depression, 155 for body image, and 141 for self-esteem.
Limitations
- The paper states high discontinuation rates in all arms, expected because the intervention was demanding and pregnancy was a reason to end participation; a statistical method was chosen to include all available data without imputation and to compensate for selective dropout if related to model variables.
- The paper states that, due to the study design, it cannot determine whether one, two, or all three components (diet, exercise, CBT) affected emotional well-being.
- Evident from the text: outcome-specific sample sizes differ across measures, and some reported p-values/effect sizes differ between the narrative and tables (e.g., self-esteem p = 0.027 in text vs p = 0.003 in Table 2), which complicates interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
2 Valid · 0 Not valid · 16 Not checked · 53 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A 5% to 10% weight loss improves many PCOS features, including psychological factors [13, 14].”
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Introduction
What the sources say
- Supportedcites [13] Teede H, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8: 41. 20591140 PMC2909929 source
The Treatment section 'Weight loss, exercise and lifestyle interventions' (p. ~7) states that 'as little as 5% to 10% weight loss has significant clinical benefits improving psychological outcomes [66], reproductive features (menstrual cyclicity, ovulation and fertility) [9,67] and metabolic features', covering both parts of the claim. The Abstract independently states that 'modest weight loss of 5% to 10% of initial body weight has been demonstrated to improve many of the features of PCOS'. The citing paraphrase faithfully reproduces the source's magnitude (5-10%) and its inclusion of psychological outcomes. (LLM, conf=0.92)
- Partly supportedcites [14] Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Human reproduction update. 2015; 21(5): 560– 74. 26060208 sourceExperimental — accuracy not yet measured
The Introduction (p. 2) supports only the general part of the claim: 'weight loss through lifestyle modification ... medications ... or bariatric surgery improves insulin resistance, reduces hyperandrogenism and alleviates PCOS clinical severity' — and there it is credited to other works (Moran et al., 2011; Vosnakis et al., 2013; Jensterle et al., 2015), not shown by this meta-analysis. The specific 5–10% magnitude is not stated as a threshold for benefit anywhere; it appears only as an intervention goal inside included trials (Table I, p. 7: Esfahanian 2012 'Dietitian review for 5-10% weight loss'; Hoeger 2004 'aim for 7-10% weight loss'). The 'including psychological factors' extension is not supported: the Discussion (p. 11) reports that 'other metabolic, reproductive or psychological outcomes did not differ significantly across comparator groups', and Secondary outcomes (p. 10) found no difference in quality of life for lifestyle + metformin versus lifestyle + placebo. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Based on their experiences, most women are not satisfied with the emotional support and help they receive [12, 62].”
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Discussion
What the sources say
- Partly supportedcites [12] Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018; 110(3): 364– 79. 30033227 PMC6939856 sourceExperimental — accuracy not yet measured
Our copy of the 2018 International Guideline does carry the general point: the INTRODUCTION states that 'women internationally have highlighted delayed diagnosis and dissatisfaction with care (3–5)', and the Abstract's 'What Is Known Already' says 'The needs of women with PCOS are not being adequately met and evidence practice gaps persist.' That supports dissatisfaction with care as reported by women themselves, but no passage in our copy addresses satisfaction specifically with the EMOTIONAL support and help received, and none quantifies it as 'most women' — the closest statements (Abstract Summary Answer, DISCUSSION, 'WHAT DOES THIS MEAN FOR ADOLESCENTS AND WOMEN WITH PCOS?') speak only of improving women's experience, partnership in care and screening/managing depressive and anxiety symptoms. The emotional-support-specific finding and the 'most women' magnitude therefore rest on the other cited source, not on this guideline. (LLM, conf=0.72)
- Not checked yetcites [62] Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017; 102(2): 604– 12. 27906550 PMC6283441
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“although body image improved significantly in both the LS without SMS (P = 0.001) and with SMS (P = 0.008) study arms.”
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Only 4 paths β out of 21 turned out to be statistically significant with self-esteem; weight loss, androstenedione, testosterone, and DHEA.”
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Results > Mediation
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The improvement within the CAU group of d = -0.12 was not statistically significant (p = 0.447), Table 2 and Fig 4.”
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Results > Body image
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
41 more claims
Create a free account to see all 71 claims and to verify the 28 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A previous 3-component lifestyle intervention consisting of diet, exercise, and cognitive behavioral therapy, facilitated using texting to track patients’ food intake, physical activity, and mood, can effectively improve eating disorder and mood in patients with PCOS and contribute to weight loss [8,9].”
From Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In five of them, either text messages providing feedback to the patients [48,49,50,51], or both text messages and phone calls with the patients are mentioned [96].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The other four publications refer to a study conducted in the Netherlands, including the 2022 report on the trial [48], two 2020 papers focusing on the primary outcome [50], and secondary analysis [49], as well as the protocol published in 2017 [51].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Abstract
“Weight loss mediated the effects on self-esteem but not on depression and body-image.”
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Discussion
“A nearly significant relationship was found between LS treatment and self-esteem mediated by weight loss”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Results > Depression
“We observed no difference between LS with SMS and LS without SMS (Cohen's d = -0.02; p = 0.939), Table 2 and Fig 2.”
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Results > Depression
“| BDI-II difference | -3.44 | -1.19 | | Cohen's d | -0.41 | 0.04 | | P value | 0.045 | 0.628 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Results > Self-esteem
“Self-esteem scores improved in the LS intervention without SMS by 2.6 points (Cohen's d = -0.44; p<0.001), and in the LS with SMS by 2.2 points (d = -0.36; p = 0.002).”
§ Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial > Results > Depression
“| Self-esteem (RSES) | Lifestyle without SMS | 18.8 | 21.5 | +2.6 | +14.0% | 0.44 | <0.001 | | Self-esteem (RSES) | Lifestyle with SMS | 19.5 | 21.7 | +2.2 | +11.2% | 0.36 | 0.002 |”
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“Homeostatic assessment of insulin resistance (HOMA-IR) was calculated from fasting insulin and glucose by the following equation: HOMA-IR = (fasting glucose (mg/dl) � fasting insulin (μIU/ml)) / 405 [39].”
MethodSociety and the Adolescent Self-Image
Rosenberg, M. (1965) · doi:10.1515/9781400876136 · Cited by 30,126
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence
Singer, J. D., & Willett, J. B. (2003) · doi:10.1093/acprof:oso/9780195152968.001.0001 · Cited by 10,647
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Statistical Analysis With Missing Data
Ghosh, S. (1988) · Technometrics · doi:10.1080/00401706.1988.10488446 · Cited by 4,576
Research works printed but not linked: 2
- Teede H, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8: 41. 20591140 PMC2909929 · DOI · Paper page
- National Collaborating Centre for Mental H, editor Depression: the treatment and management of depression in adults (updated edition) 2010: British Psychological Society. 22132433
Cited by
Update on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Moreover, the use of cognitive behavioural therapy along with lifestyle management may be an important strategy to address weight management in those with PCOS and high depressive scores 276,277 .”
Self-citationLifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 240
Depression in polycystic ovary syndrome: Focusing on pathogenesis and treatment
Xing, L., Xu, J., Wei, Y., Chen, Y., Zhuang, H., Tang, W., Yu, S., Zhang, J., Yin, G., Wang, R., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1001484 · Cited by 91
Alur-Gupta, S., Dokras, A., & Cooney, L. G. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.01.018 · Cited by 64
Low Doses of Resveratrol Protect Human Granulosa Cells from Induced-Oxidative Stress
Moreira-Pinto, B., Costa, L., Felgueira, E., Fonseca, B. M., & Rebelo, I. (2021) · Antioxidants · doi:10.3390/antiox10040561 · Cited by 42
Amiri, S., Mahmood, N., Javaid, S. F., & Khan, M. A. (2024) · Healthcare · doi:10.3390/healthcare12222263 · Cited by 59
Weight management strategies for patients with PCOS: current perspectives
Ozgen Saydam, B., & Yildiz, B. O. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1896966 · Cited by 33
Cognitive behavioural therapy for depression in women with PCOS: systematic review and meta-analysis
Jiskoot, G., van der Kooi, A.-L., Busschbach, J. J. V., Laven, J. S. E., & Beerthuizen, A. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.05.001 · Cited by 40
Self-citationEthirajulu, A., Alkasabera, A., Onyali, C. B., Anim-Koranteng, C., Shah, H. E., Bhawnani, N., & Mostafa, J. A. (2021) · Cureus · doi:10.7759/cureus.18013 · Cited by 39
Lifestyle Modifications in PCOS
Aly, J. M., & DeCherney, A. H. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000594 · Cited by 39
Kermanshahchi, J., Reddy, A. J., Xu, J., Mehrok, G. K., & Nausheen, F. (2024) · Cureus · doi:10.7759/cureus.65134 · Cited by 27
The Role of Individually Selected Diets in Obese Women with PCOS—A Review
Chudzicka-Strugała, I., Gołębiewska, I., Banaszewska, B., Brudecki, G. P., & Zwoździak, B. (2022) · Nutrients · doi:10.3390/nu14214555 · Cited by 28
Phimphasone-Brady, P., Palmer, B., Vela, A., Johnson, R. L., Harnke, B., Hoffecker, L., Coons, H. L., & Epperson, C. N. (2022) · F&S Reviews · doi:10.1016/j.xfnr.2021.11.004 · Cited by 20
Lee, I. T., Rees, J., King, S., Kim, A. E., Cherlin, T., Hinkle, S. N., Mumford, S. L., & Dokras, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae256 · Cited by 28
Pehlivan, M., Sherman, K. A., Wuthrich, V. M., Gandhi, E., Zagic, D., Kopp, E., & Perica, V. (2023) · Health Psychology Review · doi:10.1080/17437199.2023.2245020 · Cited by 23
Comprehensive transition of care for polycystic ovary syndrome from adolescence to adulthood
Simon, S. L., Phimphasone‐Brady, P., McKenney, K. M., Gulley, L. D., Bonny, A. E., Moore, J. M., Torres-Zegarra, C., & Cree‐Green, M. (2024) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(24)00019-1 · Cited by 30
Low self-esteem is related to depression and anxiety during recovery from an ectopic pregnancy
Hasani, S., Aung, E., & Mirghafourvand, M. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01467-2 · Cited by 28
Dilimulati, D., Shao, X., Wang, L., Cai, M., Zhang, Y., Lu, J., Wang, Y., Liu, H., Kuang, M., Chen, H., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/55883 · Cited by 17
“Prior studies evaluated the effectiveness of 20 cognitive behavioral therapy lifestyle courses with physical therapy, healthy eating, and 9 months of extra feedback via a mobile SMS text messaging service to conventional treatment [8].”
Weight Management in Adolescents with Polycystic Ovary Syndrome
Moore, J. M., Waldrop, S., & Cree‐Green, M. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00437-x · Cited by 23
Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome
Jing, T., Wu, Y., Wan, A., Ge, C., Chen, Z., & Du, Y. (2023) · Biomolecules · doi:10.3390/biom13071101 · Cited by 17
Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review
Graca, S., Alloh, F., Lagojda, L., Dallaway, A., Kyrou, I., Randeva, H. S., & Kite, C. (2024) · Healthcare · doi:10.3390/healthcare12161671 · Cited by 14
Female pattern hair loss and polycystic ovarian syndrome: more than just hirsutism
Jiang, V. S., Hawkins, S. D., & McMichael, A. J. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000777 · Cited by 19
Percy, C., Turner, A., & Orr, C. (2024) · JMIR Formative Research · doi:10.2196/52427 · Cited by 12
Impacts of nutrition counseling on depression and obesity: A scoping review
Milligan, M. N., Duemling, K., Radovanović, N., Alkozah, M., & Riblet, N. B. V. (2023) · Obesity Reviews · doi:10.1111/obr.13594 · Cited by 14
Understanding Insulin Actions Beyond Glycemic Control: A Narrative Review
Riachi, R., Khalife, E., Kędzia, A. W., & Niechciał, E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14145039 · Cited by 20
Association between mild depressive states in polycystic ovary syndrome and an unhealthy lifestyle
Li, L., Kang, Z., Chen, P., Niu, B., Wang, Y., & Yang, L. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1361962 · Cited by 15
Wang, G., Liu, X., Zhu, S., & Lei, J. (2024) · Journal of Advanced Nursing · doi:10.1111/jan.16220 · Cited by 18
Guo, Y., Liu, Y., Yan, X., Ding, R., & Wang, L. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.918991 · Cited by 15
Xie, M., Yang, Y., & Zhang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1297841 · Cited by 13
Schwarzinger, S., Brenner-Fließer, M., Seebauer, S., Carrus, G., Gregorio, E. D., Klöckner, C. A., & Pihkola, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32697 · Cited by 16
Pesonen, E., Nurkkala, M., Niemelä, M., Morin-Papunen, L. C., Tapanainen, J. S., Jämsä, T. J., Korpelainen, R., Ollila, M., & Piltonen, T. (2023) · Obesity · doi:10.1002/oby.23681 · Cited by 12
Effects of mind-body interventions on polycystic ovary syndrome: a comprehensive meta-analysis
Zhao, K., Nie, L., Ye, X., & Hu, X. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01477-2 · Cited by 18
Panchpuri, M., Kisku, A., Painuli, R., Pant, G., & Kumar, C. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02117-5 · Cited by 13
Considerations in the Treatment of Depression and Anxiety in Women with PCOS
Alur-Gupta, S., & Dokras, A. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777720 · Cited by 12
Orós, M., Siscart, J., Perejón, D., Serna, M. C., Godoy, P., & Salinas‐Roca, B. (2023) · Nutrients · doi:10.3390/nu15040926 · Cited by 8
de Loos, A. D., Jiskoot, G., Louwers, Y. V., Beerthuizen, A., Busschbach, J. J. V., & Laven, J. S. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020426 · Cited by 10
Self-citationMoyon, L., Gonthier, C., Brun, L., Cabagno, G., Somat, A., & Foll, D. L. (2024) · Psychology and Health · doi:10.1080/08870446.2024.2407082 · Cited by 14
Lifestyle treatment in women with polycystic ovary syndrome: predictors of weight loss and dropout
Jiskoot, G., de Loos, A. D., Timman, R., Beerthuizen, A., Laven, J. S. E., & Busschbach, J. J. V. (2022) · Brain and Behavior · doi:10.1002/brb3.2621 · Cited by 6
Self-citationImpact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
Dzienny, A. C., & Seifer, D. B. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15110518 · Cited by 7
Peng, Y., & Xie, H. (2021) · Clinical Complementary Medicine and Pharmacology · doi:10.1016/j.ccmp.2021.100007 · Cited by 4
Pesonen, E., Nurkkala, M., Ollila, M., Hurskainen, E., Morin-Papunen, L. C., Jämsä, T. J., Korpelainen, R., Niemelä, M., & Piltonen, T. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.09.042 · Cited by 9
Bridging the Gap: Integrating Awareness of Polycystic Ovary Syndrome Into Mental Health Practice
Standeven, L. R., Ho, A., & Hantsoo, L. V. (2024) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20230024 · Cited by 6
The effect of polycystic ovarian syndrome on the mental health of women of reproductive age
Adebisi, O. D., Denwigwe-aggrey, B. C., Tairu, A. B., Ozoemena, N., David, J. F., & Monday, E. O. (2021) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20212245 · Cited by 5
Wang, Y., Chen, J., Dong, H., Ma, R., Zou, Y., Wang, W., Zheng, Q., Feng, Y., Tan, Z., Zeng, X., et al. (2022) · BioMed Research International · doi:10.1155/2022/9778678 · Cited by 3
RetractedPolycystic ovary syndrome and subfertility
Ali, S. S., & Rehman, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-75945-8.00007-4 · Cited by 4
Understanding Polycystic Ovary Syndrome (PCOS): Symptoms, Diagnosis, Treatment and Future Directions
Chakravorty, T. A. (2023) · The Physician · doi:10.38192/1.8.2.3 · Cited by 9
Depression in Polycystic Ovary Syndrome: Focusing on Pathogenesis and Treatment
Xing, L., Xu, J., Wei, Y., Chen, Y., Zhuang, H., Tang, W., Yu, S., Zhang, J., Yin, G., Wang, R., et al. (2024) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021032 · Cited by 4
The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
Jiang, L., Xiao, J., Xie, L., Zheng, F., Ge, F., Zhao, X. Y., Qiang, R., Fang, J., Liu, Z., Xu, Z., et al. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01690-7 · Cited by 5
Lifestyle and psychosocial risks among women with polycystic ovary syndrome and insulin resistance
Stańczyk, K., Kolmaga, A., & Burzyńska, M. (2021) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.26444/monz/141154 · Cited by 4
Wang, G., Guan, M., Li, R., He, T., Luo, L., Hu, S., Wang, B., Liu, D., & Lei, J. (2025) · Mindfulness · doi:10.1007/s12671-025-02717-2 · Cited by 4
PCOS and Its Association with Mental Health
Alur-Gupta, S., & Dokras, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_19 · Cited by 3
Veras, A. C. O., Ordono, B. A. M., Arantes, I. C., Leite, M. G., Vargas, M. P. T. B., Valverde, M. R. V., Ribeiro, M. C. D. A. L., Teixeira, M. R., de Paiva, T. R., Cordeiro, V. S., et al. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n4-099 · Cited by 7
Sopna, S. C., Beulah Jebakani, D., Jayavani, R. L., & Sabita, P. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20231233 · Cited by 2
Shereda, H. M. A., Shokr, E. A., Radwan, H. A., Alqersh, D. L. A., Hashem, S. R., Konsouh, A. M. E.-S., Kasemy, Z. A. A., & Nada, H. E. (2025) · BMC Nursing · doi:10.1186/s12912-025-03483-1 · Cited by 9
Xie, M., Qing, X., Huang, H., Xie, B., & Zhang, J. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01167-9 · Cited by 3
Importance of lifestyle modifications
Das, B., & Fatima, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00030-x · Cited by 1
Impacto das mudanças de estilo de vida na Síndrome do Ovário Policístico – uma revisão integrativa
Gonçalves, G. C., Moreira, F. P., Fonseca, I. F., Borges, G. D., & de Siqueira, E. C. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-447 · Cited by 3
Leclerc, B., Wu, Y. C., & Wu, P. (2020) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2020.13.00517 · Cited by 1
The influence of diet on polycystic ovary syndrome
Łopuszyńska, A. M., Pawlicki, M., Kozioł, M., Krasa, A. M., Piekarska, E., & Piecewicz‐Szczęsna, H. (2021) · Journal of Education Health and Sport · doi:10.12775/jehs.2021.11.09.018 · Cited by 1
Promoción de medidas higiénico-dietéticas para el manejo del SOP, por personal de enfermería
Gabriel-Hernandez, C. S., & Ochoa‐Cortés, F. (2022) · Ciencias Huasteca Boletín Científico de la Escuela Superior de Huejutla · doi:10.29057/esh.v10i19.8176
Davis, C. C., & Popp, J. K. (2022) · Journal of Family Medicine · doi:10.26420/jfammed.2022.1285
Polycystic Ovary Syndrome – A Clinical and Psychosocial Perspective
Strzałkowska, P., Mazur, A., Dulęba, J., Sajewicz, K., Tudaj, O., Kaźmierczak, M., Kalas, W., Kalisiak, J., Koszałko, J., & Kin, F. (2025) · Quality in Sport · doi:10.12775/qs.2025.43.61284
Srivastava, M., Ampeti, S., Sonam Shashikala, B., V, Sheikh, R. B., Kirankumar, P. N., & Sali, S. R. (2025) · medtigo Journal of Medicine · doi:10.63096/medtigo3061235
Fernandes, T. S. D., Buchmann, H., Augustin, B. M., Liebl, L. C., de Castro, T. A. T., Uber, B. D. A., Fernandes, K. A., Balbinot, E. N., Alzahrani, Q. E., Franczak, P. F., et al. (2025) · Saúde Coletiva (Barueri) · doi:10.36489/saudecoletiva.2025v16i101p17314-17333
Zhao, K., Nie, L., Ye, X., & Hu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26378049
Lifestyle Management in Polycystic Ovary Syndrome
Sharma, R., & Paul, P. G. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810962125010004
Głaz, M., Deska, Ł., Zysiak, S., Głaz, D., Kamińska, N., Zaguła, J., Sołtys, W., Kosmecki, C., Stronczyński, M., & Wicha, K. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.4653
Moyon, L. (2024) · theses.fr (ABES) · doi:10.70675/dda3f186z5dddz49eaz8ec6z4d6a828f2f8b
Jeslin, G. N., Suganthirababu, P., Yugandhar, P., Bhargavi, E. S., Likitha, G. R., & Manikandan, M. (2026) · AIP conference proceedings · doi:10.1063/5.0312108
INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
Kabakchieva, P. (2026) · Anti-Aging Eastern Europe · doi:10.56543/aaeeu.2026.5.1.02
Suvetha, S., Mishra, G., Klainin‐Yobas, P., & Lim, S. (2026) · Journal of Clinical Nursing · doi:10.1111/jocn.70384
INOVAÇÕES NO MANEJO CLÍNICO DA SÍNDROME DO OVÁRIO POLICÍSTICO – UMA REVISÃO INTEGRATIVA
Sepulbeda, G. A. A., Sepulbeda, C. F. A., Junqueira, S. C. A., Rocha, B. L. D., Alciati, J. G. G., Mamani, A. J. L., & Maron, Y. L. (2026) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v7i7.8298
Sisser, P., Sheppard, C., Sevchik, A., Barnes, S., Rao, M., Gilmore, N., Reddy, P., Kudeviz, S., Knecht, M., Sacca, L., et al. (2026) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-026-00479-9
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Mcgowan, M., Cowan, S., Tay, C. T., McGowan, M. Μ., & Ng, A. H. (2026) · Experimental Physiology · doi:10.1113/ep092880 · Cited by 1
Duval, A., Berbrier, D. E., Crestol, A., Schwende, B. K., Ditto, B., & Usselman, C. W. (2026) · Journal of Health Psychology · doi:10.1177/13591053261489860
Metadata
- Authors
- Jiskoot, G., Dietz de Loos, A., Beerthuizen, A., Timman, R., Busschbach, J., & Laven, J.
- Affiliations
- Erasmus MC (NL)
- Corresponding author
- Jiskoot, Geranne
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-06-01
- Volume
- 15
- Issue
- 6
- Pages
- e0233876
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7263605
- OpenAlex
- W3029257300
- Semantic Scholar
- f4afcf346d571aa173eb093a9cbf30f77636a2cf
- Cited by
- 76
- References
- 71
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 21 · 2023: 11 · 2022: 10 · 2021: 12 · 2020: 3
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (acceptedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Danone
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Keywords
- polycystic ovary syndrome, depression, emotional well-being, self-esteem, body image, lifestyle intervention, cognitive behavioral therapy, weight loss, obesity, androgens, insulin resistance, women's mental health, pregnancy planning, diet and exercise, long-term intervention effects
- MeSH terms
- Diet, Healthy, Adult, Body Image, Combined Modality Therapy, Depression, Female, Humans, Polycystic Ovary Syndrome, Self Concept, Weight Loss, Cognitive Behavioral Therapy, Women's Health, Treatment Outcome, Physical Therapy Modalities, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.